Early research (Phase 1)Study completedNCT02186626
What this trial is testing
Evaluating the Safety and Immunogenicity of a Live Attenuated West Nile Virus Vaccine for West Nile Encephalitis in Adults 50 to 65 Years of Age
Who this might be right for
West Nile Virus
National Institute of Allergy and Infectious Diseases (NIAID) 28